Higin Capital
VC Fund
Kumamoto, Japan
Higin Capital is a VC fund in Kumamoto focused on Medical and Biotechnology. Higegin Capital is a venture capital firm.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 4%
- Fund size:
- $137M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Higin Capital invests in
Stages Higin Capital invests in
Countries Higin Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $633k–$5.4M
- Series A
- $1.2M–$9.1M
- Series B
- $3.8M–$17M
Investment Focus
Industry
- Medical 5 (19%)
- Biotechnology 5 (19%)
- Software 4 (15%)
- Medical Device 4 (15%)
- Information Technology 4 (15%)
Stage
- Series A 6 (22%)
- Series B 6 (22%)
- Venture - Series Unknown 5 (19%)
- Seed 4 (15%)
- Funding Round 3 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Akifumi Matsuo
Group Manager
|
Group Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
EUV Photon
|
EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights. | $5.4M / Seed / Jun 29, 2026 | |
Molmir
|
Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology. | $1.9M / Series A / Apr 22, 2026 | |
Restore Vision
|
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa. Restore Vision develops eye disease therapeutic agents. | $8.2M / Series B / Apr 15, 2026 | |
Photo Electron Soul
|
Photo electron Soul mission is to innovate the world of "seeing (fine observation)" and "creating (fine processing)" through the development of photocathode electron beam technology. The photocathode electron beam technology developed by our company will produce next generation electron beams with high performance andversatility (pulse structure, low dispersion, large current). By renewing the electron beam, which is a key device for industrial equipment such as electron microscopes, semiconductor device manufacturing / inspection equipment, and metal 3D printers, it is possible to realize fine observation, fine processing, high throughput, etc. Breakthroughs in a wide range of fields such as science, materials, and electronics. | $5.7M / Venture - Series Unknown / Mar 31, 2026 | |
Bluefield Energy
|
Bluefield Energy redefines Japan's electricity sector through technology-driven renewable energy solutions. Its mission centers on liberating people and society from energy constraints by tackling high costs, environmental impact, and supply instability. | $3.9M / Seed / Feb 25, 2026 | |
Surv Biopharma
|
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. | $14.1M / Series B / Nov 11, 2025 | |
KAICO
|
KAICO is a pharmaceuticals, diagnostic drugs production company. | $3.8M / Series B / Apr 15, 2025 | |
AMI
|
AMI Corp is engaged in medical consulting, medical device development and writing. | Series C / Dec 12, 2024 | |
F.MED
|
F.MED is a manufacturing company that designs and develops robotic microsurgical devices for the healthcare industry. | $2.7M / Series A / Jul 08, 2024 | |
Salmontech
|
Salmontech is a medical device company specialising in the development of ultrasound diagnostic equipment, along with related peripherals and software. Its flagship product is the wearable biosensing ultrasound probe known as "SalmonEcho." The company is dedicated to advancing medical ultrasound technology and its associated devices andsoftware. | $633.5K / Seed / Jun 18, 2024 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Higin Capital invest in?
Higin Capital invests primarily in Medical, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 27 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Higin Capital's check size?
Higin Capital typically joins rounds of $633k–$5.4M at Seed, $1.2M–$9.1M at Series A and $3.8M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Higin Capital participates in.
How do I contact Higin Capital?
Public channels for Higin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Higin Capital?
The team at Higin Capital includes Akifumi Matsuo (Group Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
